ABOUT US

Novilytic's Proteometer simplifies biopharmaceutical analytics.  Specifically, current analytical testing used in R&D relies on dated technology that requires multiple personnel, dozens of consumables, and five to six expensive instruments to obtain critical data. 

 

It provides the same answers utilizing just one person, their existing instrument, and one Proteometer consumable kit.

 

The Proteometer platform comprises three kits that analyze titer, aggregate, and charge variants of proteins containing a human Fc region, such as mAbs and multi-specifics. 

 

It is LC-agnostic and eliminates the need for Protein A purification and method development, enabling rapid, automated analysis.

 

The technology was developed by some of the brightest minds in analytical chemistry and spearheaded by Dr. Fred Regnier, formerly with Purdue University. We are fortunate to have a team of world-class chemists and business professionals who will continue to develop and promote Novilytic's cutting-edge innovations.